NCT03308045View on ClinicalTrials.gov

Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Non-infectious Uveitis
Interventions
BIOLOGICAL

pEYS606

pEYS606 is a DNA plasmid solution administered by electrotransfection into the ciliary muscle

Trial Locations (4)

38043

CHU de Grenoble - Hôpital Michallon, Grenoble

75014

Hôpital Cochin, Paris

BS1 2LX

Bristol Eye Hospital, Bristol

Unknown

Moorfields Eye Hospital, London

Sponsors

Lead Sponsor

Eyevensys
All Listed Sponsors
lead

Eyevensys

INDUSTRY